Keep up to date with our latest partnering deals and highlights
Below is a selection of news releases describing recent deals completed by AstraZeneca and our biologics arm, MedImmune.
- Wednesday, 30 July 2014
- AstraZeneca and Kyowa Hakko Kirin partner on immuno-oncology clinical study AstraZeneca today announced that it has entered into a clinical study collaboration with Kyowa Hakko Kirin for a Phase I/Ib immuno-oncology study that will evaluate the safety and efficacy of two separate combinations of three investigational compounds in multiple solid tumours.
- Thursday, 10 July 2014
- New drug active against most aggressive type of lung cancer cells Manchester scientists have shown that a new drug could prove useful in treating small cell lung cancer - the most aggressive form of lung cancer.
- Thursday, 3 July 2014
- MRC Technology and AstraZeneca Renew Collaboration to Identify Novel Targets for Discovery Research Initiative brings together global expertise to share compound libraries and streamline drug discovery